about
Classification of intrinsically disordered regions and proteinsLowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi networkEvolving nature of the AP2 alpha-appendage hub during clathrin-coated vesicle endocytosisRegulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapsesHow are the cellular functions of myosin VI regulated within the cell?Components of coated vesicles and nuclear pore complexes share a common molecular architectureContributions of epsinR and gadkin to clathrin-mediated intracellular traffickingStructure of the GAT domain of human GGA1: A syntaxin amino-terminal domain fold in an endosomal trafficking adaptorTwo distinct interaction motifs in amphiphysin bind two independent sites on the clathrin terminal domain beta-propellerThe phosphoinositide phosphatase Sjl2 is recruited to cortical actin patches in the control of vesicle formation and fission during endocytosis.Assembly of the biogenesis of lysosome-related organelles complex-3 (BLOC-3) and its interaction with Rab9Local structural disorder imparts plasticity on linear motifs.Natively unfolded domains in endocytosis: hooks, lines and linkers.Interaction between Epsin/Yap180 adaptors and the scaffolds Ede1/Pan1 is required for endocytosisThe Biochemical Properties and Functions of CALM and AP180 in Clathrin Mediated Endocytosis.Intrinsic disorder in scaffold proteins: getting more from lessStructural disorder provides increased adaptability for vesicle trafficking pathways.The ∼ 16 kDa C-terminal sequence of clathrin assembly protein AP180 is essential for efficient clathrin binding.FHL2 interacts with CALM and is highly expressed in acute erythroid leukemia.A Method for Systematic Assessment of Intrinsically Disordered Protein Regions by NMR.Nonoisotopic assay for the presynaptic choline transporter reveals capacity for allosteric modulation of choline uptake.Cancer-cell-phenotype-dependent differential intracellular trafficking of unconjugated quantum dots.Characterization of molecular recognition features, MoRFs, and their binding partnersA rapid diagnostic test for toxoplasmosis using recombinant antigenic N-terminal half of SAG1 linked with intrinsically unstructured domain of gra2 protein.Dynamic interactions between clathrin and locally structured elements in a disordered protein mediate clathrin lattice assemblyThe endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells.Analysis of Brassica napus ESTs: gene discovery and expression patterns of AP2/ERF-family transcription factors.The transmembrane tyrosine of micro-heavy chain is required for BCR destabilization and entry of antigen into clathrin-coated vesicles.Charge effects in the selection of NPF motifs by the EH domain of EHD1.The CALM and CALM/AF10 interactor CATS is a marker for proliferation.Myosin VI targeting to clathrin-coated structures and dimerization is mediated by binding to Disabled-2 and PtdIns(4,5)P2.Genetic analysis of the polyomavirus DnaJ domainTransport and release of colloidal 3-mercaptopropionic acid-coated CdSe-CdS/ZnS core-multishell quantum dots in human umbilical vein endothelial cells.A mutational analysis of the cytosolic domain of the tomato Cf-9 disease-resistance protein shows that membrane-proximal residues are important for Avr9-dependent necrosis.Intrinsically disordered C-terminal segments of voltage-activated potassium channels: a possible fishing rod-like mechanism for channel binding to scaffold proteins
P2860
Q22061736-170A791C-4697-470A-8F3B-45ABC4D74D4DQ24534275-D441BA3B-C6F1-4F81-BD78-FE817B502363Q24561365-EB15F9DD-1551-4B28-8966-FC041610877EQ24597922-DE76E9A2-DD3A-4974-99DF-2866F95E042DQ24658390-1CC3556F-11EA-4AC8-9135-0A49E1F149E8Q24805069-F432CE57-79A8-4560-9525-EF6B9AF4930EQ27305963-2A6197BC-145B-425E-9BB5-2D16590632DFQ27640868-9E412EFE-9D4B-4ACC-9EC7-E7F6309F96A8Q27643188-EC6B8BBD-E03D-42CC-A755-2D024C97477CQ27938744-26ACF326-6E32-4EE1-86B7-6082192BD122Q28115891-41DCD803-101C-4C4C-A226-2AD486069951Q30158016-1F97674B-1414-431F-8929-16575C4327FAQ30160415-B6EE7A2F-4AA9-4A7F-ACDD-EF44EF78EAD5Q30482512-5FF02FDA-303E-4FBD-9745-AF64F9FB3391Q34324323-29536E67-1239-4DBF-A962-B56FF261BA64Q34594105-CFB5C1F2-9067-481B-9513-3794030F4460Q34845322-E83EDB1F-B843-4D35-A2D1-C31FBF45AE77Q35348056-B39D9B35-0CDE-42B8-9FC4-937C21535C68Q35668394-4C998007-D9C2-4005-B881-7B7EF224A786Q35902555-E1302013-BBCD-49E4-A0DB-9D61A1827EBAQ36326822-CD6EF6D7-3D6F-48B8-9108-C6C5D389ED9FQ36422280-50A97812-131B-4377-8A99-634E178DA725Q36944291-3832D66A-8D76-474E-B848-631AEA7DB22FQ37379056-6A45ED8C-DE16-4663-B16B-ABFA63D3D540Q38340554-18E06023-1172-4AC1-A068-228CAEDAC5E9Q39160284-9F91E8D6-86A5-46E7-AE48-532906FF5BBCQ39321819-A913A500-1897-4D91-80DA-FEFA27E1A548Q40057017-2C0A60BD-5AC5-4931-B49B-8E85D4E165BFQ40125405-78CF9B32-C1C6-414A-9BE8-923AA791AED8Q41129653-C45D43AE-D902-4BDF-B79F-60E0DFF5FC31Q42155473-A7157E37-A541-4941-99E1-10417000C78AQ42812409-ACA7521D-35FE-47ED-894D-A078975D5CA7Q47768186-6955788F-0426-43EC-8A2E-D3216C6E7917Q48514111-682AAD19-4485-4858-A2A8-4557068769A2Q58061261-96FC030F-03EF-4BA7-A86A-0BD5E39A615F
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Endocytosis and vesicle trafficking.
@ast
Endocytosis and vesicle trafficking.
@en
type
label
Endocytosis and vesicle trafficking.
@ast
Endocytosis and vesicle trafficking.
@en
prefLabel
Endocytosis and vesicle trafficking.
@ast
Endocytosis and vesicle trafficking.
@en
P1476
Endocytosis and vesicle trafficking.
@en
P2093
David J Owen
Philip R Evans
P304
P356
10.1016/S0959-440X(02)00395-0
P577
2002-12-01T00:00:00Z